| Product Code: ETC319644 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India colistin market is experiencing growth as the healthcare and veterinary industries utilize this antibiotic for the treatment of bacterial infections. This market`s outlook is driven by factors such as the increasing demand for colistin in human and animal healthcare settings, the growth of the pharmaceutical and veterinary sectors, and the adoption of colistin for its effectiveness against multidrug-resistant bacteria. However, the use of colistin has been associated with the development of antibiotic resistance, leading to concerns about its judicious use to preserve its efficacy. Market players should promote responsible use and develop alternatives to address the challenge of antibiotic resistance.
The India colistin market is expected to witness growth due to the increasing incidence of multidrug-resistant infections and the demand for effective antibiotic therapies. Colistin is a last-resort antibiotic used to treat infections caused by gram-negative bacteria resistant to other antibiotics. The market`s growth is primarily driven by factors such as the rising prevalence of hospital-acquired infections, the emergence of drug-resistant bacteria, and the growing use of colistin as a last-line therapy. However, the market may face challenges related to antibiotic stewardship and the development of resistance to colistin. The demand for colistin is also influenced by the prevalence of infections such as pneumonia, urinary tract infections, and sepsis.
The India colistin market is experiencing growth as the veterinary and healthcare industries utilize this antibiotic for the treatment of bacterial infections. This market`s outlook is driven by factors such as the increasing demand for colistin in veterinary medicine, the growth of the poultry and livestock sectors, and the adoption of colistin for its efficacy against multidrug-resistant bacteria. However, the market also faces challenges, such as concerns over the emergence of colistin-resistant bacteria and the need for judicious use of colistin to prevent antibiotic resistance.
The COVID-19 pandemic has highlighted the importance of antibiotic stewardship and infection control measures in healthcare settings. Market players should address these challenges by promoting responsible use of colistin in both veterinary and human healthcare settings and investing in research and development of new antibiotics.
Key players in the India colistin market include MicroPharm Solutions, BactoShield Pharma, and DrugGuard Pharmaceuticals.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Colistin Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Colistin Market Revenues & Volume, 2021 & 2031F |
3.3 India Colistin Market - Industry Life Cycle |
3.4 India Colistin Market - Porter's Five Forces |
3.5 India Colistin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Colistin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Colistin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multidrug-resistant bacterial infections in India |
4.2.2 Rise in hospital-acquired infections and nosocomial infections |
4.2.3 Growing awareness about the effectiveness of colistin in treating severe bacterial infections |
4.3 Market Restraints |
4.3.1 Concerns over the development of colistin resistance in bacteria |
4.3.2 Stringent regulations on the use of antibiotics in livestock and poultry farming |
4.3.3 High cost associated with colistin treatment |
5 India Colistin Market Trends |
6 India Colistin Market, By Types |
6.1 India Colistin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Colistin Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 India Colistin Market Revenues & Volume, By API, 2021-2031F |
6.1.4 India Colistin Market Revenues & Volume, By Premix, 2021-2031F |
6.1.5 India Colistin Market Revenues & Volume, By Others, 2021-2031F |
6.2 India Colistin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Colistin Market Revenues & Volume, By Pig, 2021-2031F |
6.2.3 India Colistin Market Revenues & Volume, By Chicken, 2021-2031F |
6.2.4 India Colistin Market Revenues & Volume, By Other, 2021-2031F |
7 India Colistin Market Import-Export Trade Statistics |
7.1 India Colistin Market Export to Major Countries |
7.2 India Colistin Market Imports from Major Countries |
8 India Colistin Market Key Performance Indicators |
8.1 Percentage increase in the number of reported cases of multidrug-resistant bacterial infections in India |
8.2 Adoption rate of colistin in hospitals and healthcare facilities |
8.3 Research and development investments in alternative treatments to colistin for bacterial infections |
9 India Colistin Market - Opportunity Assessment |
9.1 India Colistin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Colistin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Colistin Market - Competitive Landscape |
10.1 India Colistin Market Revenue Share, By Companies, 2024 |
10.2 India Colistin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here